Press Release Hurun Pharmaceutical Global Rich List 2017

PRESS RELEASE HURUN PHARMACEUTICAL GLOBAL RICH LIST 2017

DILIP SHANGHVI (60), THE RICHEST PHARMA BILLIONAIRE

HURUN REPORT FINDS 109 PHARMACEUTICAL BILLIONAIRES

BASEL IS THE HEADQUARTER CITY TO THE MOST NUMBER OF PHARMA COMPANIES IN THE HURUN GLOBAL RICH LIST 2017

MASSIMILIANA LANDINI ALEOTTI (73) OF MENARINI, THE RICHEST WOMAN PHARMACEUTICAL BILLIONAIRE

ALL PHARMA BILLIONAIRES ARE ACTIVE IN THEIR BUSINESS

74 SELFMADE AND 35 INHERITED THEIR WEALTH

WITH 37 INDIVIDUALS, CHINA DOMINATES THE LIST FOLLOWED BY INDIA (20) AND SWITZERLAND (16)

70% OF PHARMA BILLIONAIRES DERIVE THEIR WEALTH FROM LISTED ENTITIES

18 BILLIONAIRES FROM THE PHARMA SECTOR DEBUTED HURUN GLOBAL RICH LIST 2017. BOENJAMIN SETIAWAN & FAMILY (83) OF MOTRA KELUARGA FROM INDONESIA IS THE RICHEST NEW ENTRANT

11 IMMIGRANTS. 5 TO SWITZERLAND, 4 TO USA

LEADING AUTHORITY ON ASIA’S WEALTH RELEASES HURUN GLOBAL PHARMACEUTICAL RICH LIST 2017

(12 September 2017, Shanghai, China) Hurun Report today released the Hurun Pharmaceutical Global Rich List - a ranking of the billionaires in the pharmaceutical sector found in the world. This is the first year of the ranking and is a sublist of the Hurun Global Rich List, released on 7 March.

The Hurun Pharmaceutical Global Rich List 2017 ranked 109 Pharmaceutical billionaires

Dilip Shangvi of Sun Pharma is the richest pharmaceutical billionaire, followed by Stefano Pessina of Walgreen and Cyrus Poonawalla of Serum
Among self-made billionaires, Dilip Shangvi tops the list followed by Cyrus Poonawalla.
Basel with 10 billionaires is the preferred city followed by Mumbai and Beijing with 8 and 6 billionaires respectively.
The Average age of the Pharma billionaires is 63 years

Rupert Hoogewerf, Chairman and Chief Researcher of Hurun Report, said, “Surprisingly, China has the most healthcare billionaires in the world. Surprising, because there are almost no Chinese companies amongst the world’s biggest pharma.”

Table 1: Top 10 Hurun Pharmaceutical Billionaires Global Rich List 2017

Source: Hurun Research Institute 2017

Dilip Shanghvi, 60, the pharma billionaire in India, tops the list. The founder and MD of Sun Pharmaceuticals started his pharma company with just five products and five people. Sun pharma is the largest chronic prescription company in India and offers formulations in diverse therapeutic areas, such as psychiatry, neurology, gastroenterology, cardiology and diabetology.

Stefano Pessina, 75, is the Executive Vice Chairman and Chief Executive Officer of Walgreens. He comes second in pharmaceutical billionaire in the list. Pessina joined his family’s business of pharmaceuticals in the year 1977. He bought other small pharmaceutical businesses and also modified the business structure and strategy. He has been the driving force behind the merger of Walgreens and Alliance Boots, creating the first global pharmacy-led, health and wellbeing enterprise.

Cyrus Poonawalla, 75, is the chairperson of the Poonawalla Group, which includes Serum Institute of India is one of India's top Biotech Company and one of the world’s largest vaccine producing company. The third top billionaire of the Pharmaceutical sector is a qualified doctor with a degree in anti-toxins before he parlayed his expertise into expanding the now hugely successful 350-acre stud farm started by his late father on the outskirts of Pune in 1946. Serum introduced the DTP vaccine, which protects children from diphtheria, tetanus and pertussis, followed by an anti-snake-venom serum for snakebites in 1981. He was the sole representative of India at the International Federation of Horseracing Authorities (IFHA).

Massimiliana Landini Aleotti & family, 73, is the wealthiest woman billionaire in Italy. Landini is the wife of the late Alberto Aleotti who passed away in 2014 at the age of 91. Following the death of her husband, Landini and her three children (Benedetta, Lucia, and Alberto Giovanni) were passed on the ownership of the pharmaceutical powerhouse Menarini which is considered one of Italy’s major drug firms with a total of 14 manufacturing plants and 16,000 workers worldwide.

Patrick Soon-Shiong, 64, is a surgeon, professor, researcher, entrepreneur, businessman, and philanthropist. Dr. Soon-Shiong performed the world’s first encapsulated human islet transplant, the first engineered islet cell transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA-approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer.

Ernesto Bertarelli & family, 51. The billionaire gained fame from his discovery of a natural hormone used in the treatment of female infertility. Shifting of the company's focus from pharmaceuticals to biotechnology, has helped in increasing the revenues from $809 million in 1996 to $2.8 billion in 2006.

Barry Sherman,74, the Chief Executive Officer and Chairman of Apotex Pharma, is one of the richest billionaire in Canada. Apotex pharma is Canada's largest pharmaceutical company, which sells more than 300 generic drugs in 120 countries.

Ludwig Merckle, 52, is the only heir to his father’s company the Merckle Group. Ludwig Merckle started working on the company soon after he complteted his graduation.

Sun Piaoyang & Zhong Huijuan, 59 is the head of Jiangsu Hengrui Medicine, as well as an academician. He owns a stake of 22% in Jiangsu Medicine whose drugs for cancer and tumor treatment has ranked one in terms of sales in China in the last seven years

Zhao Tao, 51, is the chairman of Shandong Buchang Pharmaceuticals, which makes traditional Chinese medicine to fight cardiovascular disease.

Where they live.

By country, China tops the list with 37 billionaires, followed by India with 20 billionaires and Switzerland with 16 billionaires. 9 new billionaires from China entered into the list. Sun Piaoyang & Zhong Huijuan is the richest billionaire from pharma sector in China.

Table 2: Pharmaceutical Billionaires by Country

Country / No of Billionaires / Richest Billionaire / Net Worth (US$bn)
1 / China / 37 / Sun Piaoyang & Zhong Huijuan / 4~7
2 / India / 20 / Dilip Shanghvi / 7~14
3 / Switzerland / 16 / Ernesto Bertarelli & family / 7~14
4 / USA / 10 / Patrick Soon-Shiong / 7~14
5 / Germany / 5 / Ludwig Merckle / 4~7

Source: Hurun Research Institute 2017

Where they live

By city, Basel leads with 10 billionaires, followed by Mumbai with 8 billionaires and Beijing with 6 billionaires. Among the 10 billionaires in Basel, 50% are women. The average wealth contributed by the pharmaceutical billionaires from Basel is US$2.4bn. Roche family is the richest billionaire from pharma sector in Basel.

Table 3: Pharmaceutical Billionaires by City

City / No of Billionaires / Richest Billionaire / Net Worth (US$bn)
1 / Basel / 10 / Roche family / >14
2 / Mumbai / 8 / Dilip Shanghvi / 7~14
3 / Beijing / 6 / Zhao Tao / 4~7
4 / Shenzhen / 5 / Ye Chenghai & Liao Qingqing / 2~4
5 / Ahmedabad / 4 / Pankaj Patel / 4~7
5 / Hyderabad / 4 / PV Ramaprasad Reddy / 2~4

Source: Hurun Research Institute 2017 * Wealth split amongst 9 family member

Top 10 Pharmaceuticals Self Made Billionaire

68% of 109 billionaires from pharmaceutical sector are self-made billionaires. Dilip Shangvi of Sun Pharma tops the list with US$14Bn, followed by Serum owner Cyrus Poonawala and Patrick Soon-Shiong with wealth US$11bn and US$9.4bn respectively.

Table 5: Top 10 Pharmaceutical Self Made Billionaires

Name / Main Company / Net Worth (US$Bn) / Age
1 / Dilip Shanghvi / Sun Pharma / 7~14 / 60
2 / Cyrus Poonawalla / Serum / 7~14 / 75
3 / Patrick Soon-Shiong / Nant Works / 7~14 / 64
4 / Barry Sherman / Apotex Pharma / 4~7 / 74
5 / Sun Piaoyang & Zhong Huijuan / Hengrui Medicine, Haosen Medicine / 4~7 / 59
6 / Zhao Tao / Buchang / 4~7 / 51
7 / Ma Xingtian & family / Kangmei / 4~7 / 48
8 / Desh Bandhu Gupta / Lupin / 4~7 / 78
9 / Wolfgang Marguerre / Octapharma / 4~7 / 75
10 / Hoang Kieu / RAAS Blood Products / 4~7 / 72

Source: Hurun Research Institute 2017

Table 6: Self-Made Score Card and Percentage of Pharmaceutical billionaires and top countries

Self-Made Scorecard / % of Pharmaceutical billionaires / Top Countries (with %. of Pharmaceutical billionaires) / Example
5 / 35% / 1. China (95%) / Self-made without parental financial support eg: Sun Piaoyang & Zhong Huijuan
2. USA (5%)
4 / 33% / 1. India (33%) / Self-made, but with a helping hand from parents such as through private education eg; Dilip Shanghvi
2 USA (19%)
3. Germany (11%)
3 / 24% / 1. India (31%) / Inherited financial independence, but grew it big time eg: Stefano Pessina
2. Switzerland (23%)
3. Italy (15%)
2 / 8% / Switzerland (89%) / Inherited, but active in the business eg:
Catherine Oeri
UK (11%)
1 / 0% / NONE / Inherited and not actively involved in the business

Source: Hurun Research Institute 2017

Interesting Facts

Dilip Shangvi has acquired over sixteen companies under him which includes Ranbaxy, Carco Pharma, and Taro Pharma. He worked as a drug distributor before deciding to make and sell his own drugs.

Dr Cyrus Poonawalla joined his family business of horse racing and breeding after completing his graduation in 1966 from University of Pune. The “Poonawalla Stud Farms” which was initially started by his late father and is now managed by him and his younger brother Zavaray. Dr. Poonawalla also has a passion for collecting fleet of luxury & sports cars – 58 to be precise, helicopters, jets & custom-built limousines and owns some of the best in the world. Some of his collections include Ferrari F-430, Rolls Royce, Cessna 560XL Citation Excel jet, Bell 407 helicopter and his recent purchase was a new Falcon 900EX business jet.

Table 7: Hurun Global Pharmaceuticals Rich List 2017

Name / Net Worth (US$Bn) / Main Company / Age / Country of Residence
Top 6 / Dilip Shanghvi / 7~14 / Sun Pharma / 60 / India
Top 6 / Stefano Pessina / 7~14 / Walgreen / 75 / Monaco
Top 6 / Cyrus Poonawalla / 7~14 / Serum / 75 / India
Top 6 / Massimiliana Landini Aleotti & family / 7~14 / Menarini / 73 / Italy
Top 6 / Patrick Soon-Shiong / 7~14 / Nant Works / 64 / USA
Top 6 / Ernesto Bertarelli & family / 7~14 / Serono / 51 / Switzerland
Top 20 / Barry Sherman / 4~7 / Apotex Pharma / 74 / Canada
Top 20 / Ludwig Merckle / 4~7 / Heidelberg Cement / 52 / Germany
Top 20 / Sun Piaoyang & Zhong Huijuan / 4~7 / Hengrui Medicine, Haosen Medicine / 59 / China
Top 20 / Zhao Tao / 4~7 / Buchang / 51 / China
Top 20 / Desh Bandhu Gupta / 4~7 / Lupin / 78 / India
Top 20 / Ma Xingtian & family / 4~7 / Kangmei / 48 / China
Top 20 / Wolfgang Marguerre / 4~7 / Octapharma / 75 / Germany
Top 20 / Frederik Paulson / 4~7 / Ferring Pharmaceuticals / 66 / Switzerland
Top 20 / Hoang Kieu / 4~7 / RAAS Blood Products / 72 / USA
Top 20 / Ajay Piramal / 4~7 / Piramal Enterprise / 60 / India
Top 20 / Pankaj Patel / 4~7 / Cadila / 65 / India
Top 20 / Xu Jingren / 4~7 / Yangtze River Pharmacy / 73 / China
Top 20 / Bernard Fraisse / 4~7 / Fareva / 60 / France
Top 20 / Alain Merieux & family / 4~7 / Bio Merieux / 79 / France
Top 20 / Robert Duggan / 4~7 / Pharmacyclics / 72 / USA
Top 20 / Zheng Yuewen / 4~7 / Creat / 55 / China
Top 50 / Boenjamin Setiawan & family / 2~4 / Mitra Keluarga / 83 / Indonesia
Top 50 / Traudl Engelhorn / 2~4 / Boehringer Mannheim / 87 / Switzerland
Top 50 / Ursula Engelhorn / 2~4 / Boehringer Mannheim / - / Switzerland
Top 50 / Phillip Frost / 2~4 / Ivax / 80 / USA
Top 50 / Daryl Katz / 2~4 / Katz / 55 / Canada
Top 50 / Andreas Strungmann / 2~4 / Hexal / 66 / Germany
Top 50 / Thomas Strungmann / 2~4 / Hexal / 66 / Germany
Top 50 / Ye Chenghai & Liao Qingqing / 2~4 / Salubris Pharmaceuticals / 74, 68 / China
Top 50 / Luca Rovati & family / 2~4 / Meda / 54 / Italy
Top 50 / Ke Zunhong & family / 2~4 / Kanghong Pharmaceuticals / 63 / China
Top 50 / Li Li & Li Tan / 2~4 / Hepalink / 53, 53 / China
Top 50 / Cao Longxiang & Zhou Guodi / 2~4 / Jumpcan / 60 / China
Top 50 / Li Yihai / 2~4 / Jiangxi Jiminkexin / 54 / China
Top 50 / An Kang & family / 2~4 / Hualan Biological Engineering / 68 / China
Top 50 / PV Ramaprasad Reddy / 2~4 / Aurobindo Pharma / 58 / India
Top 50 / Xiu Laigui & Li Yanhua / 2~4 / Xiuzheng / 62, 59 / China
Top 50 / Andre Hoffman / 2~4 / Roche / 58 / Switzerland
Top 50 / Andreas Oeri / 2~4 / Roche / 67 / Switzerland
Top 50 / Catherine Oeri / 2~4 / Roche / 61 / Switzerland
Top 50 / Jorg Duschmale / 2~4 / Roche / - / Switzerland
Top 50 / Lukas Duschmale / 2~4 / Roche / - / Switzerland
Top 50 / Maja Hoffman / 2~4 / Roche / - / Switzerland
Top 50 / Sabine Duschmale Oeri / 2~4 / Roche / 66 / Switzerland
Top 50 / Vera Michalski Hoffman / 2~4 / Roche / 62 / Switzerland
Top 50 / Jiang Wei & family / 2~4 / Bailing / 56 / China
Top 50 / Li Zongsong & Gu Xiaojia / 2~4 / Bicon / - / China
Top 50 / Xie Bing & Zheng Xiangling / 2~4 / Sino Biopharmaceutial / 65, 53 / China
Top 50 / Hasmukh Chudgar & family / 2~4 / Intas Pharma / 83 / India
Top 50 / Shoji Uehara & family / 2~4 / Taisho Pharmacuetical / 89 / Japan
Top 50 / Leonard Schleifer / 2~4 / Regeneron / 64 / USA
Top 50 / Lin Gang / 2~4 / CMS / 53 / China
Top 50 / Yan Xijun & family / 2~4 / Tasly / 64 / China
Top 100 / Samprada Singh / 1~2 / Alkem Laboratories / 91 / India
Top 100 / Seo Jung Jin / 1~2 / Celltrion / 59 / South Korea
Top 100 / Rudolf Maag / 1~2 / Actelion / 71 / Switzerland
Top 100 / Maja Oeri / 1~2 / Roche / - / Switzerland
Top 100 / Pearse Lyons / 1~2 / Alltech / 72 / USA
Top 100 / Jiang Rensheng & family / 1~2 / Zhifei Biological Prouducts / 64 / China
Top 100 / Shuai Fangwen & Cao Zaiyun / 1~2 / Er-Kang Pharmaceutical / 51, 52 / China
Top 100 / Anne Beaufour / 1~2 / Ipsen / 52 / Switzerland
Top 100 / Henri Beaufour / 1~2 / Ipsen / 50 / UK
Top 100 / Leena Tewari / 1~2 / USV / 59 / India
Top 100 / Que Wenbin / 1~2 / Duyiwei / 54 / China
Top 100 / Glenn Saldanha & family / 1~2 / Glenmark Pharma / 47 / India
Top 100 / Kiran Mazumdar-Shaw / 1~2 / Biocon / 63 / India
Top 100 / Mannalal B Agarwal & family / 1~2 / Ajanta Pharma / 69 / India
Top 100 / B Parthasaradhi Reddy / 1~2 / Hetero group of companies / 62 / India
Top 100 / Hu Kaijun / 1~2 / CheChc / - / China
Top 100 / Yusuf Hamied / 1~2 / Cipla / 80 / India
Top 100 / John Martin / 1~2 / - / 65 / USA
Top 100 / Lei Jufang / 1~2 / Qizheng Pharmaceutical / 64 / China
Top 100 / Lin Mingzhang / 1~2 / Creat / - / China
Top 100 / Wu Yiling & family / 1~2 / Yiling Pharmaceutical / 68 / China
Top 100 / Zhu Baoguo & famiy / 1~2 / Joint Care / 55 / China
Top 100 / Randal Kirk / 1~2 / Intrexon Corp / 63 / USA
Top 100 / Fang Tonghua & family / 1~2 / ZBD Pharmaceutical / 54 / China
Top 100 / Alberto Chiesi / 1~2 / Chiesi Farmaceutici / - / Italy
Top 100 / Paulo Chiesi / 1~2 / Chiesi Farmaceutici / - / Italy
Top 100 / John Kapoor / 1~2 / Insys Therapeutics / 73 / USA
Top 100 / Salman & Ahmed Rahman / 1~2 / Beximco / 49 / Bangladesh
Top 100 / Marc Coucke / 1~2 / Omega Pharma / 52 / Belgium
Top 100 / Samir Mehta / 1~2 / Torrent Pharma / 53 / India
Top 100 / Sudhir Mehta / 1~2 / Torrent Pharma / 61 / India
Top 100 / Stephen Saad / 1~2 / Aspen / 52 / South Africa
Top 100 / Stewart Rahr / 1~2 / Kinray / 70 / USA
Top 100 / Zeng Lingshan / 1~2 / Creat / - / China
Top 100 / Zhu Jiman & Bai Lihui / 1~2 / Gloria Pharmaceuticals / 53, 52 / China
Top 100 / Willy Micheal / 1~2 / Ypsomed / 70 / Switzerland
Top 100 / Bulent Eczacibasi / 1~2 / Eczacibasi / 67 / Turkey
Top 100 / Faruk Eczacibasi / 1~2 / Eczacibasi / 62 / Turkey
Top 100 / Wang Junmin / 1~2 / Haisco Pharmaceutical / 49 / China
Top 100 / GV Prasad / 1~2 / Dr. Reddy's Lab / 55 / India
Top 100 / Lim Sung-Ki / 1~2 / Hanmi Science / 76 / South Korea
Top 100 / Che Fengsheng / 1~2 / Sihuan Pharm / 55 / China
Top 100 / Cheng Xianfeng / 1~2 / Yifan Xinfu Pharmaceutical / 49 / China
Top 100 / Dong Fan / 1~2 / Jafron Biomedical / 47 / China
Top 100 / Han Xu & Zhang Renhua / 1~2 / Realcan Pharmaceutical / 52, 51 / China
Top 100 / Li Zhengguo / 1~2 / Youbo Pharmaceutical / 57 / China
Top 100 / Yang Wenlong & family / 1~2 / Renhe / 55 / China
Top 100 / Zhang Simin & Wang Jinsong / 1~2 / Neptunus / 55, - / China
Top 100 / Zhu Wenchen / 1~2 / Furen Medicine / 51 / China
Top 100 / Francisco Deusmar de Queiros / 1~2 / Pague Menos / 68 / Brazil
Top 100 / Erwin Franz Mueller / 1~2 / Mueller / 84 / Germany
Top 100 / K Satish Reddy / 1~2 / Dr. Reddy's Lab / 49 / India
Top 100 / Rajeev Juneja / 1~2 / Mankind Pharma / 51 / India
Top 100 / Ramesh Juneja / 1~2 / Mankind Pharma / 61 / India
Top 100 / Hirokazu Sugiara & family / 1~2 / Sugi Holdings / 66 / Japan

About Hurun Report Inc.

Nobody Knows China’s Rich Better!

Established as a research unit in 1999 by British accountant Rupert Hoogewerf, Hurun Report Inc. has grown into a leading research house, media and lifestyle investments business based in Shanghai, China, best-known for its rankings of the richest people in China, India and the rest of the world.

Hurun Report Inc. has four divisions: Hurun Research Institute; Hurun Media; Hurun Conferences and Training, an active events division targeting entrepreneurs and high net worth individuals; and Hurun Lifestyle and Investments, with investments in education, interior design, horses, bespoke tailoring, media and retail.

For further information, see

For media inquiries, please contact:

Hurun Report

Porsha Pan

Tel: +86-21-50105808*601

Mobile: +86-139 1838 7446

Email:

1 / 9